Agenus Inc. (AGEN) was a big mover last session, as the company saw its shares shoot up over 11% on the day. This significant rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $2.94 to $3.95 in the past one-month time frame, showed a pick-up yesterday at $3.39.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Agenus currently has a Zacks Rank #3(Hold) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Actelion Ltd. (ALIOF) and Biogen Idec Inc. (BIIB) carrying a Zacks Rank #1 (Strong Buy) and Amicus Therapeutics, Inc. (FOLD) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AGENUS INC (AGEN): Free Stock Analysis Report
AMICUS THERAPEUTICS INC (FOLD): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading